The evidence-first AI framework for value-based care

Traditional healthcare AI often relies on isolated, one-off models that generate probability scores without context. EVE replaces this approach with a unified, evidence-first AI engine that links insights directly to source documentation and applies consistent logic across risk and quality programs.

No. EVE is a shared AI technology layer embedded in the Reveleer’s value-based care enablement platform that powers our products and solutions. There is no separate “EVE product” for customers to purchase or manage.

EVE encompasses Hybrid AI (Gen AI-based evidence extraction plus deterministic formulas), Agentic AI pipelines, Clinical NLP (including LLM-enhanced techniques), supervised predictive models, and an AI voice agent used only within the retrieval solution

Agentic AI refers to AI systems designed to take purposeful actions such as extracting evidence, validating information, or routing work. These actions occur within defined rules and human oversight. In EVE, agentic AI performs specific tasks in the risk and quality workflow while remaining transparent, governed, and non-autonomous.

No. EVE’s high stakes use cases are evidence-based and predictive. It analyzes and structures existing data and applies transparent logic, rather than synthesizing new clinical narratives or diagnoses.

All EVE capabilities operate under a structured MLOps and governance framework with continuous monitoring, bias and drift checks, controlled updates, and mandatory human validation for coding and clinical decisions.